{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:56:48Z","timestamp":1793015808411,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.euroneuro.2004.01.002","type":"journal-article","created":{"date-parts":[[2004,3,16]],"date-time":"2004-03-16T05:24:03Z","timestamp":1079414643000},"page":"457-470","source":"Crossref","is-referenced-by-count":216,"title":["Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial"],"prefix":"10.1016","volume":"14","author":[{"given":"Michael J.","family":"Detke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis G.","family":"Wiltse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig H.","family":"Mallinckrodt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Demitrack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istvan","family":"Bitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2004.01.002_BIB1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-0327(99)00092-0","article-title":"Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability","volume":"58","author":"Anderson","year":"2000","journal-title":"J. Affect. Disord"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/hrp.7.5.257","article-title":"The efficacy of newer antidepressants in the treatment of chronic pain: a review of current literature","volume":"7","author":"Ansari","year":"2000","journal-title":"Harv. Rev. Psychiatry"},{"issue":"Suppl. 26","key":"10.1016\/j.euroneuro.2004.01.002_BIB3","first-page":"5","article-title":"New standard of depression treatment: remission and full recovery","volume":"62","author":"Bakish","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archpsyc.1986.01800050099013","article-title":"Hypochondriasis. An evaluation of the DSM-III criteria in medical outpatients","volume":"43","author":"Barsky","year":"1986","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB5","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0149-2918(00)83028-3","article-title":"Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: an updated meta-analysis","volume":"22","author":"Beasley","year":"2000","journal-title":"Clin. Ther"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB6","first-page":"3277","article-title":"Anxiety and depression\u2014a common mixture","volume":"119","author":"Bjelland","year":"1999","journal-title":"Tidsskr. Nor. Laegeforen"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1185\/030079902125001461","article-title":"The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France","volume":"19","author":"Bonierbale","year":"2003","journal-title":"Curr. Med. Res. Opin"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB8","article-title":"Comparison of sexual functioning in patients receiving duloxetine or paroxetine: acute- and long-term data","author":"Brannan","year":"2003"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB9","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/sj.npp.1300209","article-title":"Duloxetine increases serotonin and norepinephrine availability in healthy subjects: a double-blind, controlled study","volume":"28","author":"Chalon","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-0447.1997.tb09630.x","article-title":"Partial remission in depressive disorders","volume":"95","author":"Cornwall","year":"1997","journal-title":"Acta Psychiatr. Scand"},{"issue":"Suppl. 7","key":"10.1016\/j.euroneuro.2004.01.002_BIB11","first-page":"4","article-title":"The underrecognition and undertreatment of depression: what is the breadth and depth of the problem?","volume":"60","author":"Davidson","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1213\/00000539-199801000-00020","article-title":"The visual analog scale in the immediate postoperative period: intrasubject variability and correlation with a numeric scale","volume":"86","author":"DeLoach","year":"1998","journal-title":"Anesth. Analg"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4088\/JCP.v63n0407","article-title":"Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial","volume":"63","author":"Detke","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-3956(02)00060-2","article-title":"Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression","volume":"36","author":"Detke","year":"2002","journal-title":"J. Psychiatr. Res"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB15","series-title":"Comorbidity of Mood and Anxiety Disorders","first-page":"205","article-title":"Syndrome and symptom co-occurrence in the anxiety disorders","author":"Di Nardo","year":"1990"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB16","first-page":"21","article-title":"Optimal dose regimen for paroxetine","volume":"53","author":"Dunner","year":"1992","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000068689","article-title":"A self-controlled, naturalistic study of selective serotonin reuptake inhibitors versus tricyclic antidepressants","volume":"72","author":"Faravelli","year":"2003","journal-title":"Psychother. Psychosom"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4088\/JCP.v63n0406","article-title":"Somatic symptoms, depression, and antidepressant treatment","volume":"63","author":"Fava","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB19","doi-asserted-by":"crossref","first-page":"863","DOI":"10.4088\/JCP.v61n1109","article-title":"Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment","volume":"61","author":"Fava","year":"2000","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl. 6","key":"10.1016\/j.euroneuro.2004.01.002_BIB20","first-page":"32","article-title":"Efficacy issues with antidepressants","volume":"58","author":"Fawcett","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB21","first-page":"8","article-title":"Anxiety syndromes and their relationship to depressive illness","volume":"44","author":"Fawcett","year":"1983","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB22","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1176\/ajp.147.9.1189","article-title":"Time-related predictors of suicide in major affective disorder","volume":"147","author":"Fawcett","year":"1990","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/07853890008995932","article-title":"Evidence-based data on pain relief with antidepressants","volume":"32","author":"Fishbain","year":"2000","journal-title":"Ann. Med"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00002508-199706000-00006","article-title":"Chronic pain-associated depression: antecedent or consequence of chronic pain? A review","volume":"13","author":"Fishbain","year":"1997","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/oby.2001.71","article-title":"Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women","volume":"9","author":"Gadde","year":"2001","journal-title":"Obes. Res"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1345\/aph.19079","article-title":"Factors affecting prescribing of the newer antidepressants","volume":"34","author":"Garrison","year":"2000","journal-title":"Ann. Pharmacother"},{"issue":"Suppl. 15","key":"10.1016\/j.euroneuro.2004.01.002_BIB27","first-page":"13","article-title":"Cardiovascular effects of antidepressant drugs: updated","volume":"59","author":"Glassman","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4088\/JCP.v63n0309","article-title":"Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial","volume":"63","author":"Goldstein","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB29","doi-asserted-by":"crossref","DOI":"10.1097\/01.jcp.0000132448.65972.d9","article-title":"Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine","author":"Goldstein","year":"2004","journal-title":"J. Clin. Psychopharmacol"},{"issue":"Suppl. 16","key":"10.1016\/j.euroneuro.2004.01.002_BIB30","first-page":"26","article-title":"The burden of disease for treatment-resistant depression","volume":"62","author":"Greden","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB31","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00002826-198810000-00006","article-title":"Major depressive disorder and panic disorder. Effects of comorbidity on treatment outcome with antidepressant medications","volume":"11","author":"Grunhaus","year":"1988","journal-title":"Clin. Neuropharmacol"},{"issue":"Suppl. 10","key":"10.1016\/j.euroneuro.2004.01.002_BIB32","first-page":"5","article-title":"Problems with currently available antidepressants","volume":"61","author":"Gumnick","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB33","series-title":"ECDEU Assessment Manual for Psychopharmacology, Revised 1976","author":"Guy","year":"1976"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"Assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Suppl. 42","key":"10.1016\/j.euroneuro.2004.01.002_BIB36","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1192\/bjp.179.42.s4","article-title":"Clinical importance of long-term antidepressant treatment","author":"Hirschfeld","year":"2001","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0165-0327(99)00050-6","article-title":"Sexual dysfunction before antidepressant therapy in major depression","volume":"56","author":"Kennedy","year":"1999","journal-title":"J. Affect. Disord"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey","volume":"51","author":"Kessler","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB39","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1176\/ajp.150.5.734","article-title":"Somatization and the recognition of depression and anxiety in primary care","volume":"150","author":"Kirmayer","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB40","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1001\/archinte.153.21.2474","article-title":"Symptoms in the community. Prevalence, classification, and psychiatric comorbidity","volume":"153","author":"Kroenke","year":"1993","journal-title":"Arch. Intern. Med"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/00926239808414663","article-title":"Sexual dysfunction induced by serotonin reuptake antidepressants","volume":"24","author":"Labbate","year":"1998","journal-title":"J. Sex Marital Ther"},{"issue":"Suppl. 4","key":"10.1016\/j.euroneuro.2004.01.002_BIB42","first-page":"12","article-title":"Measuring onset of antidepressant action in clinical trials: an overview of definitions and methodology","volume":"62","author":"Leon","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00004850-199701000-00003","article-title":"Depression in the community: the first pan-European Study DEPRES (Depression Research in European Society)","volume":"12","author":"Lepine","year":"1997","journal-title":"Int. Clin. Psychopharmacol"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB44","first-page":"30","article-title":"Antidepressants as analgesics: a review of randomized controlled trials","volume":"26","author":"Lynch","year":"2001","journal-title":"J. Psychiatry Neurosci"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB45","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1517\/14656566.1.5.917","article-title":"Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression","volume":"1","author":"Mace","year":"2000","journal-title":"Expert Opin. Pharmacother"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1081\/BIP-100104194","article-title":"Accounting for dropout bias using mixed-effects models","volume":"11","author":"Mallinckrodt","year":"2001","journal-title":"J. Biopharm. Stat"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB47","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1177\/009286150103500418","article-title":"Type I error rates from mixed effects model repeated measures versus fixed effects ANOVA with missing values imputed via Last Observation Carried Forward","volume":"35","author":"Mallinckrodt","year":"2001","journal-title":"Drug Inf. J"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/009262300278623","article-title":"The Arizona Sexual Experience Scale (ASEX): reliability and validity","volume":"26","author":"McGahuey","year":"2000","journal-title":"J. Sex Marital Ther"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB49","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","article-title":"Descending control of pain","volume":"66","author":"Millan","year":"2002","journal-title":"Prog. Neurobiol"},{"issue":"Suppl. 3","key":"10.1016\/j.euroneuro.2004.01.002_BIB50","first-page":"10","article-title":"Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients","volume":"62","author":"Montejo","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB51","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"issue":"Suppl. 6","key":"10.1016\/j.euroneuro.2004.01.002_BIB52","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/00004850-199807006-00005","article-title":"Depression: a long-term illness and its treatment","volume":"13","author":"Montgomery","year":"1998","journal-title":"Int. Clin. Psychopharmacol"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB53","series-title":"The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020","author":"Murray","year":"1996"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB54","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archpsyc.1991.01810280019002","article-title":"A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression","volume":"48","author":"Nelson","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB55","first-page":"106","article-title":"Duloxetine for the treatment of major depressive disorder","volume":"36","author":"Nemeroff","year":"2002","journal-title":"Psychopharmacol. Bull"},{"issue":"Suppl. 22","key":"10.1016\/j.euroneuro.2004.01.002_BIB56","first-page":"7","article-title":"Evolution of remission as the new standard in the treatment of depression","volume":"60","author":"Nierenberg","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB57","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1017\/S0033291700033146","article-title":"Residual symptoms after partial remission: an important outcome in depression","volume":"25","author":"Paykel","year":"1995","journal-title":"Psychol. Med"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB58","series-title":"Physicians' Desk Reference","author":"PDR","year":"2002"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB59","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1176\/ajp.154.12.1757","article-title":"Sexual functioning in chronically depressed patients treated with SSRI antidepressants: a pilot study","volume":"154","author":"Piazza","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB60","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJM199108293250907","article-title":"The pharmacologic treatment of depression","volume":"325","author":"Potter","year":"1991","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB61","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4088\/JCP.v64n1015","article-title":"Duloxetine in the long-term treatment of major depressive disorder","volume":"64","author":"Raskin","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB62","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1176\/ajp.155.9.1247","article-title":"Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment","volume":"155","author":"Reimherr","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB63","series-title":"Depressive Disorders","first-page":"401","article-title":"Costs of depressive disorders","author":"Rosenbaum","year":"1999"},{"issue":"Suppl. 3","key":"10.1016\/j.euroneuro.2004.01.002_BIB64","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0924-977X(99)00027-9","article-title":"Anxiety with depression: a treatment need","volume":"9","author":"Rouillon","year":"1999","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB65","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1055\/s-2001-14420","article-title":"Anxiety and depression in the general population over 60 years old","volume":"126","author":"Schwarz","year":"2001","journal-title":"Dtsch. Med. Wochenschr"},{"issue":"Suppl. 3","key":"10.1016\/j.euroneuro.2004.01.002_BIB66","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004850-199606003-00015","article-title":"The measurement of disability","volume":"11","author":"Sheehan","year":"1996","journal-title":"Int. Clin. Psychopharmacol"},{"issue":"Suppl. 20","key":"10.1016\/j.euroneuro.2004.01.002_BIB67","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB68","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM199910283411801","article-title":"An international study of the relation between somatic symptoms and depression","volume":"341","author":"Simon","year":"1999","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB69","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0304-3959(99)00154-2","article-title":"Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action","volume":"83","author":"Sindrup","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB70","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4088\/JCP.v60n0401","article-title":"Why settle for silver, when you can go for gold? Response vs. recovery as the goal of antidepressant therapy","volume":"60","author":"Stahl","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB71","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0006-3223(02)01425-7","article-title":"Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression","volume":"52","author":"Stahl","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB72","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1520-6394(1997)6:1<10::AID-DA2>3.0.CO;2-9","article-title":"Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis","volume":"6","author":"Steffens","year":"1997","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB73","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0165-0327(95)00002-5","article-title":"Mixed anxiety\u2013depression in a primary-care clinic","volume":"34","author":"Stein","year":"1995","journal-title":"J. Affect. Disord"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB74","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4088\/JCP.v59n1002","article-title":"Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients","volume":"59","author":"Thase","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB75","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1192\/bjp.178.3.234","article-title":"Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors","volume":"178","author":"Thase","year":"2001","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB76","series-title":"Routine Laboratory Tests in Clinical Trials","first-page":"1","author":"Thompson","year":"1990"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB77","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00004714-200302000-00011","article-title":"Dual monoamine modulation for improved treatment of major depressive disorder","volume":"23","author":"Tran","year":"2003","journal-title":"J. Clin. Psychopharmacol"},{"key":"10.1016\/j.euroneuro.2004.01.002_BIB78","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-0348-8183-8_5","article-title":"Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype?","volume":"58","author":"Wong","year":"2002","journal-title":"Prog. Drug Res"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X04000161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X04000161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T11:55:18Z","timestamp":1550145318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X04000161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0924977X04000161"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2004.01.002","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}